title: The effects of curcumin on the liver and remote organs after hepatic ischemia reperfusion injury formed with Pringle manoeuvre in rats.
abstract: BACKGROUND
  We aimed to investigate the effects of curcumin on ischemia/ reperfusion (IR) injury of the liver and distant organs resulting from liver blood flow arrest.
  
  
  METHODS
  Totally 40 rats, divided into four groups, each included 10 rats were used. Group I as only laparatomy, Group II laparatomy and curcumin application, Group III hepatic IR; and Group IV as hepatic IR and curcumin application group. Ischemia was generated by hepatoduedonal ligament clamping for 30 minutes and then reperfusion is started. Curcumin capsules were opened and appropriate dose had been created within weighing scales. After calculations, the powder was diluted with saline. Fifteen minutes before the ischemia, curcumin was applied via oral gavage. Blood samples were taken from the animals for biochemical analysis at 60th minutes of the experiment in the first and second groups; 30 minutes after beginning reperfusion in the third and forth groups. Simultaneously, liver, lung and kidney tissues were sampled for biochemical and histopathological examinations.
  
  
  RESULTS
  Plasma malondialdehyde levels were found to be higher (p < 0.001), but total antioxidant activity values were not different in IR group compared with IR + curcumin group (p > 0.05). Biochemical and histopathological evaluation of tissue samples revealed that there were no differences in total antioxidant activity, total oxidant activity and histopathologic scores in IR + curcumin group compared with values of IR group (p > 0.05).
  
  
  CONCLUSIONS
  Curcumin did not reduce the effects of hepatic ischemia reperfusion injury on the liver and distant organs including kidneys and lungs significantly.
authors.affiliation: Department of General Surgery, Ceylanpinar State Hospital, Sanliurfa, Turkey.
authors.forename: A
authors.initials: A
authors.lastname: Oguz
authors.forename: M
authors.initials: M
authors.lastname: Kapan
authors.forename: A
authors.initials: A
authors.lastname: Onder
authors.forename: E
authors.initials: E
authors.lastname: Kilic
authors.forename: M
authors.initials: M
authors.lastname: Gumus
authors.forename: M K
authors.initials: MK
authors.lastname: Basarali
authors.forename: U
authors.initials: U
authors.lastname: Firat
authors.forename: A
authors.initials: A
authors.lastname: Boyuk
authors.forename: S
authors.initials: S
authors.lastname: Buyukbas
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D003474:Curcumin / Q000008:administration & dosage / Q000627:therapeutic use*; D004195:Disease Models, Animal; D007511:Ischemia / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D015227:Lipid Peroxidation / Q000187:drug effects; D008099:Liver / Q000098:blood supply* / Q000187:drug effects / Q000473:pathology; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D009928:Organ Specificity; D051381:Rats; D017208:Rats, Wistar; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology
chemical_list: D000975:Antioxidants; D008315:Malondialdehyde; D003474:Curcumin